Ginwa Enterprise GroupSHSE:600080 -1.20%47 Interest Coverage is 15.14 as of Mar. 2026, which is 179% above its 10-year median of 5.43. GuruFocus rates SHSE:600080 with a GF Score™ of 47/100 and a GF Value™ of ¥7.53 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 685 Drug Manufacturers companies, Ginwa Enterprise Group ranks worse than 85.4% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Ginwa Enterprise Group's
Operating Income
for the
three
months ended in Mar. 2026 was ¥10.6 Mil. Ginwa Enterprise Group's Interest Expense for the
three
months ended in Mar. 2026 was ¥-0.7 Mil.
Ginwa Enterprise Group's interest coverage for the quarter that ended in Mar. 2026 was 15.14.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Ginwa Enterprise Group's Interest Coverage or its related term are showing as below:
SHSE:600080'
s Interest Coverage Range Over the Past 10 Years
Min: 1.11 Med: 5.43 Max: 53.43
Current: 2.07
SHSE:600080's Interest Coverage is ranked worse than 85.4% of 685
companies
in the Drug Manufacturers industry
Industry Median: 12.75
vs SHSE:600080: 2.07
Ginwa Enterprise Group (SHSE:600080) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Ginwa Enterprise Group Interest Coverage Related Terms
Ginwa Enterprise Group Interest Coverage Historical Data
* Premium members only.
The historical data trend for Ginwa Enterprise Group's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
SHSE:600080 vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ginwa Enterprise Group's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ginwa Enterprise Group Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ginwa Enterprise Group's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Ginwa Enterprise Group's Interest Coverage falls into.
Ginwa Enterprise Group Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ginwa Enterprise Group (SHSE:600080) has a Interest Coverage of 15.14 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Ginwa Enterprise Group and its competitors. This is 179% above median its historical median of 5.43. Over the past decade, Ginwa Enterprise Group's Interest Coverage has ranged from 1.11 to 53.43. According to the industry distribution chart, Ginwa Enterprise Group ranks #585 out of 685 companies in the Drug Manufacturers industry, placing it in the top 85.4%.
Is Ginwa Enterprise Group's Interest Coverage too high?
Ginwa Enterprise Group's current Interest Coverage of 15.14 is 179% above median its 10-year median of 5.43. Over the past 10 years, this metric has ranged from a low of 1.11 to a high of 53.43. The Drug Manufacturers industry median Interest Coverage is 12.75. Ginwa Enterprise Group's value of 15.14 is 18.7% above this industry median. Based on the distribution chart, Ginwa Enterprise Group ranks #585 out of 685 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Ginwa Enterprise Group has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ginwa Enterprise Group's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ginwa Enterprise Group ranks #585 out of 685 companies for Interest Coverage. This places Ginwa Enterprise Group in the lower half of its industry. The industry median Interest Coverage is 12.75. Ginwa Enterprise Group's value of 15.14 is 18.7% above this benchmark. Historically, Ginwa Enterprise Group's own Interest Coverage has ranged from 1.11 to 53.43 over the past decade. While the company's 10-year median is 5.43 vs. the industry median of 12.75, Ginwa Enterprise Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ginwa Enterprise Group's current Interest Coverage of 15.14 is 18.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Ginwa Enterprise Group and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ginwa Enterprise Group's current Interest Coverage is 15.14, which is 179% above median its own 10-year median of 5.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginwa Enterprise Group stock overvalued right now?
Based on GuruFocus' analysis, Ginwa Enterprise Group (SHSE:600080) is currently considered Possible Value Trap. The stock's GF Value™ is ¥7.53, compared to a current price of ¥4.94 — trading 34.4% below its estimated fair value. The current Interest Coverage is 15.14, which is 179% above median its 10-year median of 5.43 and 18.7% above the Drug Manufacturers industry median of 12.75. Ginwa Enterprise Group's overall GF Score™ is 47/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Ginwa Enterprise Group (SHSE:600080), the current Interest Coverage is 15.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ginwa Enterprise Group (SHSE:600080) Overvalued in 2026?
Based on GuruFocus' analysis, Ginwa Enterprise Group stock appears to be undervalued.
The current stock price of ¥4.94 is trading 34.4% below its estimated GF Value™ of ¥7.53.
GuruFocus considers Ginwa Enterprise Group to be Possible Value Trap.
Key valuation signals for SHSE:600080:
Interest Coverage: 15.14 (179% above median its 10-year median of 5.43)
GF Value™: ¥7.53 vs. price of ¥4.94 (34.4% below fair value)
Industry Position: 18.7% above the Drug Manufacturers median (#585 of 685)
No single metric tells the full story. See the SHSE:600080 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ginwa Enterprise Group Inc operates in the pharmaceutical industry. The main business is the research and development, production, and sales of drugs, and the product line covers chemical drugs, Chinese patent medicines, raw materials, and health products. The dosage forms include tablets, capsules, granules, powders, mixtures, oral solutions, syrups, external solutions, and more than 100 varieties and specifications.
47GF Score
Get the complete analysis for SHSE:600080
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600080 has been successfully added to your 
